Clinical Trials in Illinois

Showing 17381-17400 of 19,692 trials

Fecal Microbiota Therapy for Recurrent Clostridium Difficile Colitis

NCT01973465

This study was developed in response to the July, 2013 FDA draft guidance regarding FMT for CDI. The weight of the evidence in the literature suggests that FMT is the most effective treatment for ambulatory outpatients affected by recurrent CDI who fail conventional therapy. The anticipated benefits to research patients enrolled in this study include resolution of chronic diarrhea, return of bowel habits and nutritional status to normal, and resolution of chronic recurrent CDI. FMT involves the endoscopic instillation of freshly obtained stool with millions of live bacteria into the recipient's colon by endoscopic lavage. With any endoscopic procedure, there is a risk of perforated viscous. This is very rare, but the risk is increased with severe CDI. The risk of acquisition of communicable enteric or blood borne pathogen appears to be negligible.

Clostridium Difficile

OSF Healthcare System10 participantsStarted Sep 2013

Peoria, Illinois, United States

COMPLETEDPhase 3103 miles

A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone

NCT00457392

This study will test whether treatment with erlotinib plus SU011248 is better than erlotinib alone in patients with advanced/metastatic lung cancer who have received previous treatment with a platinum-based regimen.

Carcinoma, Non-Small Cell Lung

Pfizer960 participantsStarted Jul 2007

Florence, Alabama, United States • Muscle Shoals, Alabama, United States • Scottsdale, Arizona, United States +201 more locations

Fecal Microbiota Therapy for Recurrent Clostridium Difficile Colitis

A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone

Find Trials by Condition in Illinois

Tiotropium (18 Mcg) Once Daily Via the HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD)

A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza

Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma

Safety, Tolerability, and Antiviral Activity of 24 or 48 Weeks of GS-9190 in Combination With Peginterferon Alfa 2a and Ribavirin for the Treatment of Genotype-1 Chronic HCV Infection

The Primary Objective of This Study is to Determine Whether MICARDIS® Improves Insulin Sensitivity in Overweight or Obese, Non-diabetic, Normotensive Subjects

A 6 Week Trial to Study the Efficacy and Safety of a Starting Dose 0.25 mg Pramipexole (Mirapex) in Patients With RLS

A Fourteen-Week Placebo-Controlled Dose-Response Efficacy and Safety Study of NS 2330 in Early Parkinson's Disease Patients (Study for Proof of Concept in Early Parkinson's Disease of a Triple Reuptake Inhibitor, NS 2330 / SCEPTRE)

Collection of Follow-up Data From CP-690,550-treated Kidney Transplant Recipients

Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver Disease

12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPD

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Brain Metastases

A Study of PEGASYS (Pegylated-interferon Alfa-2a) With or Without Ribavirin in Patients With Chronic Hepatitis C Who Have Participated in Previous Roche or Roche Partner Protocols

A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy

A Thyroid Hormone Analog to Fight Heart Failure: Phase II Trial (DITPA)

High Dose Trial in COPD

Pericoital Oral Contraception With Levonorgestrel

Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer